Home
Crosslink

Eye Care News: Trials Deliver, Evidence Divides

Ophthalmology and optometry news and links from 9/21/26 to 9/28/26. Editor’s Pick of the Week What The Data Say About GLP-1 Drugs and Vision Loss – American Academy of Ophthalmology September 22, 2026 The AAO and NANOS reviewed more than 40 studies and found semaglutide may carry about a two-fold relative risk of NAION, though...

More Top Stories

Home
Retina

Beacon’s One-Time Gene Therapy Improves Low-Light Vision in Phase II XLRP Trial

Laru-zova clears its primary endpoint in the dark. Now comes the brighter glare of regulatory review. X-linked retinitis pigmentosa (XLRP) has no approved treatment, but a one-time gene therapy may help patients hold their own once the lights go down. Beacon Therapeutics (London, UK) reported that its pivotal Phase II/III VISTA trial met its primary...

The latest in ophthalmology dropping daily from conferences worldwide…stay tuned for live updates!

Search conference by name and year

Search conference
Year